Paper10219843
Influence of cholestasis on absorption of ursodeoxycholic acid.
Sauer P and 5 others. Dig Dis Sci, 1999. Cited by 27 papers, by iCite.
Cite this record
ConductScience Library. Influence of cholestasis on absorption of ursodeoxycholic acid. Papers, record 10219843. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10219843
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cholagogues and Choleretics | Major topic |
| Cholestasis | Major topic |
| Pancreatic Neoplasms | Major topic |
| Ursodeoxycholic Acid | Major topic |
| Administration, Oral | |
| Aged | |
| Bile Acids and Salts | |
| Bilirubin | |
| Drainage | |
| Female | |
| Humans | |
| Intestinal Absorption | |
| Male | |
| Middle Aged |
Source PubMed
References37
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 864325 | Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chromatorgaphy-mass spectrometry. | J Lipid Res | 1977 | https://conductscience.org/library/papers/864325 | PubMed |
| 2 | 1505913 | Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial. | Hepatology | 1992 | https://conductscience.org/library/papers/1505913 | PubMed |
| 3 | 2365199 | Asymptomatic primary sclerosing cholangitis treated with ursodeoxycholic acid. | Gastroenterology | 1990 | https://conductscience.org/library/papers/2365199 | PubMed |
| 4 | 1959845 | Changes in bile acid composition in patients with primary biliary cirrhosis induced by ursodeoxycholic acid administration. | Hepatology | 1991 | https://conductscience.org/library/papers/1959845 | PubMed |
| 5 | 1937390 | Ursodeoxycholic acid for the treatment of primary sclerosing cholangitis: a 30-month pilot study. | Hepatology | 1991 | https://conductscience.org/library/papers/1937390 | PubMed |
| 6 | 1537519 | Intestinal absorption of ursodeoxycholic acid in patients with extrahepatic biliary obstruction and bile drainage. | Gastroenterology | 1992 | https://conductscience.org/library/papers/1537519 | PubMed |
| 7 | 7557144 | Vesicle targeting to the apical domain regulates bile excretory function in isolated rat hepatocyte couplets. | Gastroenterology | 1995 | https://conductscience.org/library/papers/7557144 | PubMed |
| 8 | 2777202 | Effect of ursodeoxycholic acid on bile acid metabolism in primary biliary cirrhosis. | Hepatology | 1989 | https://conductscience.org/library/papers/2777202 | PubMed |
| 9 | 2295398 | Acute effects of ursodeoxycholic and chenodeoxycholic acid on the small intestinal absorption of bile acids. | Gastroenterology | 1990 | https://conductscience.org/library/papers/2295398 | PubMed |
| 10 | 8254052 | Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis. | J Clin Invest | 1993 | https://conductscience.org/library/papers/8254052 | PubMed |
| 11 | 1590390 | Regulatory volume decrease stimulates bile flow, bile acid excretion, and exocytosis in isolated perfused rat liver. | Am J Physiol | 1992 | https://conductscience.org/library/papers/1590390 | PubMed |
| 12 | 2401455 | Ursodeoxycholic acid-induced changes of plasma and urinary bile acids in patients with primary biliary cirrhosis. | Hepatology | 1990 | https://conductscience.org/library/papers/2401455 | PubMed |
| 13 | 7657280 | A randomized, double-blind, placebo-controlled trial of ursodeoxycholic acid in primary biliary cirrhosis. | Hepatology | 1995 | https://conductscience.org/library/papers/7657280 | PubMed |
| 14 | 1847897 | Regulation of bile acid synthesis. | Hepatology | 1991 | https://conductscience.org/library/papers/1847897 | PubMed |
| 15 | 8290601 | Regulation of activity and apical targeting of the Cl-/HCO3- exchanger in rat hepatocytes. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8290601 | PubMed |
| 16 | 8175136 | The Canadian Multicenter Double-blind Randomized Controlled Trial of ursodeoxycholic acid in primary biliary cirrhosis. | Hepatology | 1994 | https://conductscience.org/library/papers/8175136 | PubMed |
| 17 | 8617445 | Adaptive response of the enterohepatic circulation of bile acids to extrahepatic cholestasis. | Hepatology | 1996 | https://conductscience.org/library/papers/8617445 | PubMed |
| 18 | 8201224 | Effect of ursodeoxycholic acid on liver and bile duct disease in primary sclerosing cholangitis. A 3-year pilot study with a placebo-controlled study period. | J Hepatol | 1994 | https://conductscience.org/library/papers/8201224 | PubMed |
| 19 | 8174890 | Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. | Gastroenterology | 1994 | https://conductscience.org/library/papers/8174890 | PubMed |
| 20 | 6724256 | Differences in the effects of chenodeoxycholic and ursodeoxycholic acid on biliary lipid secretion and bile acid synthesis in patients with gallstones. | Gastroenterology | 1984 | https://conductscience.org/library/papers/6724256 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42298049 | The longstanding issue of the benefit of ursodeoxycholic acid in primary sclerosing cholangitis: a long-term population-based study. | J Gastroenterol | 2026 | https://conductscience.org/library/papers/42298049 | PubMed |
| 36830173 | Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth. | Antibiotics (Basel) | 2023 | https://conductscience.org/library/papers/36830173 | PubMed |
| 31671869 | Preclinical Evaluation of UDCA-Containing Oral Formulation in Mice for the Treatment of Wet Age-Related Macular Degeneration. | Pharmaceutics | 2019 | https://conductscience.org/library/papers/31671869 | PubMed |
| 20564380 | Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression. | Hepatology | 2010 | https://conductscience.org/library/papers/20564380 | PubMed |
| 17391626 | Treatment of primary sclerosing cholangitis. | Curr Treat Options Gastroenterol | 2007 | https://conductscience.org/library/papers/17391626 | PubMed |
| 16773706 | Ursodeoxycholic acid treatment of vanishing bile duct syndromes. | World J Gastroenterol | 2006 | https://conductscience.org/library/papers/16773706 | PubMed |
| 16614977 | Effect of colitis and ileoanal pouch on biliary enrichment of ursodeoxycholic acid in primary sclerosing cholangitis. | Dig Dis Sci | 2006 | https://conductscience.org/library/papers/16614977 | PubMed |
| 16150853 | Adaptive regulation of the ileal apical sodium dependent bile acid transporter (ASBT) in patients with obstructive cholestasis. | Gut | 2006 | https://conductscience.org/library/papers/16150853 | PubMed |
| 15609388 | Primary sclerosing cholangitis: updates in diagnosis and therapy. | World J Gastroenterol | 2005 | https://conductscience.org/library/papers/15609388 | PubMed |
| 14735241 | [Primary sclerosing cholangitis]. | Internist (Berl) | 2004 | https://conductscience.org/library/papers/14735241 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/10219843
GET https://conductscience.org/api/papers/v1/10219843/references?page=2